Marker Therapeutics, Inc. (MRKR)
0.90
-0.05
(-5.27%)
USD |
NASDAQ |
Nov 12, 16:00
0.918
+0.02
(+2.00%)
After-Hours: 20:00
Marker Therapeutics Free Cash Flow (Quarterly) : -3.716M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.716M |
| March 31, 2026 | -1.404M |
| December 31, 2025 | -1.900M |
| September 30, 2025 | -2.736M |
| June 30, 2025 | -1.878M |
| March 31, 2025 | -5.500M |
| December 31, 2024 | -4.703M |
| September 30, 2024 | 1.198M |
| June 30, 2024 | -3.568M |
| March 31, 2024 | -3.837M |
| December 31, 2023 | -2.368M |
| September 30, 2023 | -1.128M |
| June 30, 2023 | -7.057M |
| March 31, 2023 | -5.888M |
| December 31, 2022 | -6.305M |
| September 30, 2022 | -2.928M |
| June 30, 2022 | -3.061M |
| March 31, 2022 | -14.68M |
| December 31, 2021 | -5.208M |
| September 30, 2021 | -8.516M |
| June 30, 2021 | -7.250M |
| March 31, 2021 | -9.437M |
| December 31, 2020 | -9.604M |
| September 30, 2020 | -7.354M |
| June 30, 2020 | -8.18M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.150M |
| December 31, 2019 | -4.574M |
| September 30, 2019 | -5.721M |
| June 30, 2019 | -4.262M |
| March 31, 2019 | -4.103M |
| December 31, 2018 | -6.310M |
| September 30, 2018 | -3.572M |
| June 30, 2018 | -2.399M |
| March 31, 2018 | -2.346M |
| December 31, 2017 | -2.478M |
| September 30, 2017 | -2.025M |
| June 30, 2017 | -2.012M |
| March 31, 2017 | -1.924M |
| December 31, 2016 | -1.754M |
| September 30, 2016 | -1.972M |
| June 30, 2016 | -1.954M |
| March 31, 2016 | -0.8298M |
| December 31, 2015 | -0.851M |
| September 30, 2015 | -1.665M |
| June 30, 2015 | -0.8132M |
| March 31, 2015 | -1.014M |
| December 31, 2014 | -0.6692M |
| September 30, 2014 | -0.9065M |
| June 30, 2014 | -0.238M |
| March 31, 2014 | -0.3735M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 34.35M |
| ACADIA Pharmaceuticals, Inc. | 10.26M |
| Alnylam Pharmaceuticals, Inc. | 271.15M |
| Anika Therapeutics, Inc. | 6.716M |
| Savara, Inc. | -42.82M |